181 related articles for article (PubMed ID: 32119084)
1. Isolation of highly selective IgNAR variable single-domains against a human therapeutic Fc scaffold and their application as tailor-made bioprocessing reagents.
Buschhaus MJ; Becker S; Porter AJ; Barelle CJ
Protein Eng Des Sel; 2019 Dec; 32(9):385-399. PubMed ID: 32119084
[TBL] [Abstract][Full Text] [Related]
2. VNAR single-domain antibodies specific for BAFF inhibit B cell development by molecular mimicry.
Häsler J; Flajnik MF; Williams G; Walsh FS; Rutkowski JL
Mol Immunol; 2016 Jul; 75():28-37. PubMed ID: 27213814
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies for the identification and purification of vNAR domains and IgNAR immunoglobulins from the horn shark Heterodontus francisci.
Juarez K; Dubberke G; Lugo P; Koch-Nolte F; Buck F; Haag F; Licea A
Hybridoma (Larchmt); 2011 Aug; 30(4):323-9. PubMed ID: 21851231
[TBL] [Abstract][Full Text] [Related]
4. Isolation of a pH-Sensitive IgNAR Variable Domain from a Yeast-Displayed, Histidine-Doped Master Library.
Könning D; Zielonka S; Sellmann C; Schröter C; Grzeschik J; Becker S; Kolmar H
Mar Biotechnol (NY); 2016 Apr; 18(2):161-7. PubMed ID: 26838965
[TBL] [Abstract][Full Text] [Related]
5. Construction of Histidine-Enriched Shark IgNAR Variable Domain Antibody Libraries for the Isolation of pH-Sensitive vNAR Fragments.
Könning D; Hinz S; Grzeschik J; Schröter C; Krah S; Zielonka S; Kolmar H
Methods Mol Biol; 2018; 1827():109-127. PubMed ID: 30196494
[TBL] [Abstract][Full Text] [Related]
6. Generation of Semi-Synthetic Shark IgNAR Single-Domain Antibody Libraries.
Grzeschik J; Könning D; Hinz SC; Krah S; Schröter C; Empting M; Kolmar H; Zielonka S
Methods Mol Biol; 2018; 1701():147-167. PubMed ID: 29116504
[TBL] [Abstract][Full Text] [Related]
7. Phage Display Derived IgNAR V Region Binding Domains for Therapeutic Development.
Ubah OC; Barelle CJ; Buschhaus MJ; Porter AJ
Curr Pharm Des; 2016; 22(43):6519-6526. PubMed ID: 27604606
[TBL] [Abstract][Full Text] [Related]
8. Identification of Anti-TNFα VNAR Single Domain Antibodies from Whitespotted Bambooshark (
Zhao L; Chen M; Wang X; Kang S; Xue W; Li Z
Mar Drugs; 2022 Apr; 20(5):. PubMed ID: 35621957
[TBL] [Abstract][Full Text] [Related]
9. Semi-synthetic vNAR libraries screened against therapeutic antibodies primarily deliver anti-idiotypic binders.
Könning D; Rhiel L; Empting M; Grzeschik J; Sellmann C; Schröter C; Zielonka S; Dickgießer S; Pirzer T; Yanakieva D; Becker S; Kolmar H
Sci Rep; 2017 Aug; 7(1):9676. PubMed ID: 28852148
[TBL] [Abstract][Full Text] [Related]
10. Isolation and Characterization of Targeting-HBsAg VNAR Single Domain Antibodies from Whitespotted Bamboo Sharks (
Jiang X; Sun S; Li Z; Chen M
Mar Drugs; 2023 Apr; 21(4):. PubMed ID: 37103376
[TBL] [Abstract][Full Text] [Related]
11. Generation of VNAR Libraries from Immunized Sharks and Selection of Target-Specific Clones.
Dooley H
Methods Mol Biol; 2022; 2421():57-72. PubMed ID: 34870811
[TBL] [Abstract][Full Text] [Related]
12. Exploring shark VNAR antibody against infectious diseases using phage display technology.
Lim HT; Kok BH; Leow CY; Leow CH
Fish Shellfish Immunol; 2023 Sep; 140():108986. PubMed ID: 37541634
[TBL] [Abstract][Full Text] [Related]
13. Structural insights and biomedical potential of IgNAR scaffolds from sharks.
Zielonka S; Empting M; Grzeschik J; Könning D; Barelle CJ; Kolmar H
MAbs; 2015; 7(1):15-25. PubMed ID: 25523873
[TBL] [Abstract][Full Text] [Related]
14. Ancient species offers contemporary therapeutics: an update on shark V
English H; Hong J; Ho M
Antib Ther; 2020 Jan; 3(1):1-9. PubMed ID: 32118195
[TBL] [Abstract][Full Text] [Related]
15. Selection and Characterization of Anti-idiotypic Shark Antibody Domains.
Könning D; Zielonka S; Kaempffe A; Jäger S; Kolmar H; Schröter C
Methods Mol Biol; 2020; 2070():191-209. PubMed ID: 31625097
[TBL] [Abstract][Full Text] [Related]
16. The Shark Strikes Twice: Hypervariable Loop 2 of Shark IgNAR Antibody Variable Domains and Its Potential to Function as an Autonomous Paratope.
Zielonka S; Empting M; Könning D; Grzeschik J; Krah S; Becker S; Dickgießer S; Kolmar H
Mar Biotechnol (NY); 2015 Aug; 17(4):386-92. PubMed ID: 26003538
[TBL] [Abstract][Full Text] [Related]
17. The influence of antibody humanization on shark variable domain (VNAR) binding site ensembles.
Fernández-Quintero ML; Fischer AM; Kokot J; Waibl F; Seidler CA; Liedl KR
Front Immunol; 2022; 13():953917. PubMed ID: 36177031
[TBL] [Abstract][Full Text] [Related]
18. Dimerisation strategies for shark IgNAR single domain antibody fragments.
Simmons DP; Abregu FA; Krishnan UV; Proll DF; Streltsov VA; Doughty L; Hattarki MK; Nuttall SD
J Immunol Methods; 2006 Aug; 315(1-2):171-84. PubMed ID: 16962608
[TBL] [Abstract][Full Text] [Related]
19. Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain.
Müller MR; Saunders K; Grace C; Jin M; Piche-Nicholas N; Steven J; O'Dwyer R; Wu L; Khetemenee L; Vugmeyster Y; Hickling TP; Tchistiakova L; Olland S; Gill D; Jensen A; Barelle CJ
MAbs; 2012; 4(6):673-85. PubMed ID: 23676205
[TBL] [Abstract][Full Text] [Related]
20. Construction and next-generation sequencing analysis of a large phage-displayed V
Feng M; Bian H; Wu X; Fu T; Fu Y; Hong J; Fleming BD; Flajnik MF; Ho M
Antib Ther; 2019 Jan; 2(1):1-11. PubMed ID: 30627698
[No Abstract] [Full Text] [Related]
[Next] [New Search]
